These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1430 related items for PubMed ID: 23436669

  • 1. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A, Giannuzzi R, Sollazzo F, Petrongolo L, Bernardini L, Dain S.
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [Abstract] [Full Text] [Related]

  • 2. Psychiatric emergencies (part I): psychiatric disorders causing organic symptoms.
    Testa A, Giannuzzi R, Sollazzo F, Petrongolo L, Bernardini L, Daini S.
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():55-64. PubMed ID: 23436668
    [Abstract] [Full Text] [Related]

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM, avec le soutien institutionnel du laboratoire Lilly.
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [Abstract] [Full Text] [Related]

  • 4. Psychiatric emergencies (part III): psychiatric symptoms resulting from organic diseases.
    Testa A, Giannuzzi R, Daini S, Bernardini L, Petrongolo L, Gentiloni Silveri N.
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():86-99. PubMed ID: 23436670
    [Abstract] [Full Text] [Related]

  • 5. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ, Garlapati V.
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [Abstract] [Full Text] [Related]

  • 6. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S, Stip E, Roy JY.
    Encephale; 2003 Dec; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [Abstract] [Full Text] [Related]

  • 7. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C, Polard E, Mauduit N, Allain H.
    Encephale; 2001 Dec; 27(4):351-9. PubMed ID: 11686057
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis and psychopharmacology of dual disorders.
    Decker KP, Ries RK.
    Psychiatr Clin North Am; 1993 Dec; 16(4):703-18. PubMed ID: 8309808
    [Abstract] [Full Text] [Related]

  • 9. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ, Muzinić L, Radeljak S.
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [Abstract] [Full Text] [Related]

  • 10. [Alpha-interferon and mental disorders].
    Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.
    Encephale; 2001 Sep; 27(4):308-17. PubMed ID: 11686052
    [Abstract] [Full Text] [Related]

  • 11. [Psychiatric emergencies in drug addiction].
    Benyamina A, Bouchez J, Rahioui H, Reynaud M.
    Rev Prat; 2003 Jun 01; 53(11):1201-8. PubMed ID: 15185645
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology of psychiatric disorders in Edmonton. Drug abuse and dependence.
    Russell JM, Newman SC, Bland RC.
    Acta Psychiatr Scand Suppl; 1994 Jun 01; 376():54-62. PubMed ID: 8178686
    [Abstract] [Full Text] [Related]

  • 13. Adolescent substance abuse and psychiatric comorbidities.
    Deas D.
    J Clin Psychiatry; 2006 Jun 01; 67 Suppl 7():18-23. PubMed ID: 16961420
    [Abstract] [Full Text] [Related]

  • 14. The dually diagnosed patient with psychotic symptoms.
    Ries RK.
    J Addict Dis; 1993 Jun 01; 12(3):103-22. PubMed ID: 8251538
    [Abstract] [Full Text] [Related]

  • 15. [Clinical and prognostic characteristics associated with addictive comorbidity in hospitalized psychiatric patients].
    Liraud F, Verdoux H.
    Encephale; 2000 Jun 01; 26(3):16-23. PubMed ID: 10951902
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H, Mury M, Besançon G, Bourgeois M.
    Encephale; 1996 Jun 01; 22(2):95-101. PubMed ID: 8706627
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL, Estroff TW, Empting LD, Shearer-Williams S, Hoffmann NG.
    J Addict Med; 2013 Jun 01; 7(1):17-24. PubMed ID: 23131838
    [Abstract] [Full Text] [Related]

  • 18. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL, Coste J, Bigot T, Ferrand I.
    Encephale; 2000 Jun 01; 26(6):11-20. PubMed ID: 11217533
    [Abstract] [Full Text] [Related]

  • 19. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF, Noordsy DL, Xie H, Drake RE.
    Psychiatr Serv; 2003 Oct 01; 54(10):1395-401. PubMed ID: 14557527
    [Abstract] [Full Text] [Related]

  • 20. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.
    Encephale; 2009 Jun 01; 35(3):226-33. PubMed ID: 19540408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.